Target intelligence / Profile preview

Periodontal bacteria

Molecular classification
Bacteria, Microorganism
01

Overview

Periodontal bacteria refer to a diverse group of predominantly anaerobic microorganisms that colonize the subgingival environment and are the primary etiological agents of periodontal diseases, such as gingivitis and periodontitis (StatPearls, 2023). Key pathogens include the 'red complex' (Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia) as well as Aggregatibacter actinomycetemcomitans (Socransky et al., 1998). These bacteria organize into complex biofilms, or dental plaque, which protect them from host immune responses and facilitate the release of virulence factors like lipopolysaccharides and proteases (Hajishengallis, 2015). These factors trigger a chronic inflammatory response in the host, leading to the destruction of the supporting structures of the teeth, including the gingiva, periodontal ligament, and alveolar bone (Pihlstrom et al., 2005). Therapeutic strategies involve mechanical debridement supplemented by local or systemic antimicrobial agents that target bacterial cell walls, protein synthesis, or metabolic pathways (NIH, 2023). Beyond oral health, periodontal bacteria have been increasingly linked to systemic conditions, including cardiovascular disease and diabetes, due to the dissemination of bacteria and inflammatory mediators into the bloodstream (Hajishengallis, 2015).

Other names
Periodontal pathogensOral microbiotaRed complex bacteriaSubgingival biofilm
02

Mechanism of action

Antimicrobial agents target periodontal bacteria by inhibiting cell wall synthesis, inhibiting protein synthesis by binding to 30S or 50S ribosomal subunits, or disrupting DNA synthesis and structural integrity.

03

Biological functions

Biofilm formationHost-pathogen interactionProteolysisInflammatory response induction
04

Disease associations

PeriodontitisGingivitisCardiovascular diseaseDiabetes mellitusAlzheimer's diseaseInfection
05

Safety considerations

Development of antimicrobial resistanceDisruption of commensal oral flora (dysbiosis)Systemic side effects of antibioticsHypersensitivity reactions
06

Interacting drugs

Amoxicillin

5 more in the full profile.

07

Biomarkers

Probing pocket depth (PPD)Bleeding on probing (BOP)Clinical attachment loss (CAL)Gingival crevicular fluid (GCF) cytokinesBacterial DNA load

Beyond the preview

Go deeper on Periodontal bacteria.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Periodontal bacteria.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call